LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,829 | 6,411 | 2,861 | 4,021 | 5,610 |
| Marketable Securities | 39,080 | 66,466 | 20,204 | 28,112 | 47,115 |
| TOTAL | $43,913 | $73,780 | $23,848 | $33,090 | $53,444 |
| Non-Current Assets | |||||
| PPE Net | 2,333 | 4,037 | 6,059 | 6,206 | 6,034 |
| Intangibles | 3,279 | 3,111 | 3,119 | 2,648 | 2,386 |
| TOTAL | $5,612 | $7,148 | $9,178 | $8,854 | $8,420 |
| Total Assets | $49,525 | $80,928 | $33,026 | $41,944 | $61,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,125 | 866 | 1,455 | 278 | 1,846 |
| Accrued Expenses | 3,932 | 2,289 | 3,918 | 3,081 | 4,614 |
| TOTAL | $6,240 | $3,656 | $6,309 | $4,176 | $6,954 |
| Non-Current Liabilities | |||||
| Long Term Debt | 196 | 142 | 716 | 1,312 | 1,111 |
| TOTAL | $196 | $142 | $716 | $1,341 | $1,111 |
| Total Liabilities | $6,436 | $3,798 | $7,025 | $5,517 | $8,065 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,712 | 32,535 | 73,759 | 61,125 | 42,483 |
| Common Shares | 327 | 325 | 123 | 511 | 425 |
| Retained earnings | -299,757 | -260,312 | -232,949 | -192,405 | -153,567 |
| Other shareholders' equity | 0 | 0 | -23 | -73 | 36 |
| TOTAL | $43,089 | $77,130 | $26,001 | $36,427 | $53,799 |
| Total Liabilities And Equity | $49,525 | $80,928 | $33,026 | $41,944 | $61,864 |